viagra

GBT created Oxbryta tablets, a initially-in-class medicine that directly targets the root lead to of SCD. Oxbryta was approved in the U.S. in November 2019 and is also approved in the EU, United Arab Emirates, Oman and Great Britain. Leveraging its global platform, Pfizer plans to accelerate distribution of GBT’s...

More
  • October 21, 2022